| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039969778 |
| P356 | DOI | 10.2165/00003495-197918050-00001 |
| P698 | PubMed publication ID | 389600 |
| P50 | author | Rex N. Brogden | Q62563651 |
| P2093 | author name string | Pakes GE | |
| Avery GS | |||
| Heel RC | |||
| Speight TM | |||
| P2860 | cites work | Interaction of glipizide with human serum albumin | Q34648531 |
| Pharmacokinetics of glipizide in man: Influence of renal insufficiency | Q34700096 | ||
| Comparison of the pharmacokinetics of glipizide and glibenclamide in man | Q34728399 | ||
| Metabolites of hypoglycemic sulfonylureas in kidney failure. Experience with glibenclamide | Q39625726 | ||
| Comparative study of the hypoglycaemic and antilipolytic effects of four antidiabetic agents administered i.v | Q39783928 | ||
| Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas | Q39784983 | ||
| Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients | Q40874614 | ||
| Glipizide in the treatment of maturity-onset diabetes: a multi-centre, out-patient study | Q40898248 | ||
| Glipizide (‘Glibenese’) in maturity-onset diabetes mellitus | Q41063662 | ||
| Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus | Q41318388 | ||
| Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024) | Q43545152 | ||
| Clinical evaluation of glipizide. Results of a multicentric study in Spain | Q43546043 | ||
| Effect of glipizide on the release of insulin in the perfused rat pancreas in vitro | Q43666872 | ||
| Metabolism and Kinetics of the Hypoglycemic Agent Glipizide in Man—Comparison with Glibenclamide | Q44370062 | ||
| Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide. | Q44682369 | ||
| A controlled study of the hypoglycemic and insulinopoietic effect of glipizide and glibenclamide in non-diabetic human subjects | Q44716265 | ||
| Metabolism of glipizide in the rat and dog and its tissue distribution in the mouse | Q48682382 | ||
| Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide. | Q51679284 | ||
| Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic | Q53739870 | ||
| Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases. | Q53898763 | ||
| Effect of glipizide on a double-meal test in diabetic patients. | Q53940603 | ||
| Glipizide versus tolbutamide in maturity-onset diabetes, an open comparative study | Q54170682 | ||
| An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide. | Q54170720 | ||
| Interactions of sulfonylureas with plasma proteins. | Q54273107 | ||
| [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus] | Q54431973 | ||
| Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden) | Q54467706 | ||
| Sulphonylureas increase the number of insulin receptors | Q59086797 | ||
| Diazoxide, glipizide, hypertension and hypoglycaemia | Q66706024 | ||
| Diazoxide, glipizide, and hypoglycaemia | Q66706837 | ||
| [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)] | Q67527367 | ||
| [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration] | Q67573650 | ||
| Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs | Q67676051 | ||
| Glipizide--a new oral antidiabetic | Q67713454 | ||
| Glipizide-phenformin combination in the treatment of diabetes mellitus | Q68231092 | ||
| [Clinical trial of a new oral antidiabetic: glypizide] | Q68810353 | ||
| [Clinical experimentation with a new hypoglycemic agent (glipizide)] | Q69209315 | ||
| New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial | Q69226364 | ||
| Clinical study with glipizide, a new oral antidiabetic drug | Q69314825 | ||
| [Hypoglycemic effect of glipizide. Study in 20 diabetic patients with low pancreatic insulin reserve] | Q69344571 | ||
| A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024) | Q69460988 | ||
| Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea | Q69462633 | ||
| Clinical experience with glipizide in the treatment of mostly complicated diabetes | Q69645426 | ||
| Clinical trial of glypizide | Q69760820 | ||
| Pharmacokinetics and metabolism of N-(4-( -(5-methylpyrazine-2-carboxyamido)-ethyl)-benzensulfonyl)-N'cyclohexylurea (K 4024) in experimental animals and in man | Q70415081 | ||
| Clinical experience concerning the action of a new oral antidiabetic drug: glidiazinamide | Q71810254 | ||
| P433 | issue | 5 | |
| P921 | main subject | glipizide | Q3108899 |
| P304 | page(s) | 329-353 | |
| P577 | publication date | 1979-11-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Glipizide: a review of its pharmacological properties and therapeutic use. | |
| P478 | volume | 18 |
| Q46970225 | Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers |
| Q70449262 | Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics |
| Q40307292 | Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs |
| Q34714607 | Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. |
| Q41201529 | Clinically significant drug interactions with cyclosporin. An update |
| Q34124052 | Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus |
| Q54487407 | Glipizide: An overview |
| Q39847061 | Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use. |
| Q44432959 | Lack of weight gain associated with short-term astemizole treatment |
| Q38050497 | Octreotide for the treatment of sulfonylurea poisoning |
| Q34347249 | Pharmacogenetics of warfarin elimination and its clinical implications |
| Q40888885 | Prospective multicenter study of sulfonylurea ingestion in children |
| Q34589896 | Severe Hypoglycaemia During Treatment with Glipizide |
| Q34327147 | Simultaneous quantification of metformin and glipizide in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study |
| Q36660303 | The Management of Diabetes Mellitus in Older Individuals |
| Q33487832 | The enhancing effect of ion-pairing on the skin permeation of glipizide |
| Q39662366 | The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs |
Search more.